Clinical Trials
3 trialsNCT03251989 2026-05-29
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Completed
NCT02162732 2025-11-03
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Phase NA Completed
NCT03173950 2025-06-29
Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed